Comparison of Pharmacokinetics and Safety of Voriconazole Intravenous-to-Oral Switch in Immunocompromised Children and Healthy Adults

Voriconazole pharmacokinetics are not well characterized in children despite prior studies. To assess the appropriate pediatric dosing, a study was conducted in 40 immunocompromised children aged 2 to <12 years to evaluate the pharmacokinetics and safety of voriconazole following intravenous (IV)...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Driscoll, Timothy A., Yu, Lolie C., Frangoul, Haydar, Krance, Robert A., Nemecek, Eneida, Blumer, Jeffrey, Arrieta, Antonio, Graham, Michael L., Bradfield, Scott M., Baruch, Alice, Liu, Ping
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2011
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232783/
https://ncbi.nlm.nih.gov/pubmed/21968355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00531-11
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak